BioCentury
ARTICLE | Financial News

InnaVirVax completes venture financing

July 13, 2015 7:00 AM UTC

InnaVirVax S.A., Evry, France Business: Infectious, Cancer Date completed: 2015-07-09 Type: Venture financing Raised: EUR3.6 million ($4 million) Investors: CapDecisif; G1J; Pradeyrol Developpement; F...